Celerion Announces Investment in ADME Suite of Services

Published on: 

Celerion has announced that it has made a significant investment in its ADME (Absorption, Distribution, Metabolism and Excretion) suite of services to meet continuously increasing demand to conduct these studies. This investment includes expanding laboratory space, adding new capabilities as well as a dedicated customer service team.

Read more about Celerion's new investment here.